- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 207/38 - Pyrrolones-2
Détention brevets de la classe C07D 207/38
Brevets de cette classe: 185
Historique des publications depuis 10 ans
18
|
10
|
5
|
10
|
10
|
11
|
4
|
11
|
15
|
0
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Novartis AG | 11238 |
13 |
The University of British Columbia | 1432 |
8 |
Bayer Cropscience AG | 2241 |
7 |
British Columbia Cancer Agency Branch | 195 |
7 |
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 157 |
7 |
The University of Queensland | 666 |
7 |
Conopco, Inc. | 4644 |
6 |
Syngenta Participations AG | 4970 |
6 |
Bristol-myers Squibb Company | 5080 |
5 |
Unilever PLC | 3540 |
5 |
Ottawa Hospital Research Institute | 102 |
5 |
University of Ottawa | 200 |
5 |
Unilever N.V. | 3440 |
4 |
Poseidon Pharmaceutical Co., Ltd. | 10 |
4 |
Wuhan Dapeng Pharmaceutical Co., Ltd. | 10 |
4 |
Bayer Intellectual Property GmbH | 2671 |
3 |
Cocrystal Pharma, Inc. | 43 |
3 |
Shionogi & Co., Ltd. | 914 |
3 |
Vectus Biosystems Limited | 36 |
3 |
Beijing Joekai Biotech. LLC | 4 |
3 |
Autres propriétaires | 77 |